51765-10-7

Basic information

• Product Name: 2-[(Z)-3-hydroxy-1-propenyl]-4-methylphenol
• Synonyms: 2-[(Z)-3-hydroxy-1-propenyl]-4-methylphenol
• CAS NO: 51765-10-7
• Molecular Weight: 164.204
• Mol File: 51765-10-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-[(Z)-3-hydroxy-1-propenyl]-4-methylphenol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(Z)-3-hydroxy-1-propenyl]-4-methylphenol(51765-10-7)
• EPA Substance Registry System: 2-[(Z)-3-hydroxy-1-propenyl]-4-methylphenol(51765-10-7)

Safety Data

• Hazardous Substances Data: 51765-10-7(Hazardous Substances Data)

Upstream product

• 92-48-8 6-methylcoumarin 

Downstream Products

• 18385-83-6 6-methyl-2H-chromene 
• 300767-43-5 2-[(Z)-2-(benzylmethylcarbamoyl)vinyl]-4-methylphenyl acetate 
• 300767-39-9 2-[(Z)-3-{[1-(tert-butyl)-1,1-dimethyl-silanyl]oxy}-1-propenyl]-4-methylphenyl acetate 
• 300767-44-6 2-[(Z)-2-(diethylcarbamoyl)vinyl]-4-methylphenyl acetate 
• 300767-42-4 (Z)-3-[2-(acetyloxy)-5-methylphenyl]acrylic acid 
• 300767-40-2 2-[(Z)-3-hydroxy-1-propenyl]-4-methylphenyl acetate 
• 300767-41-3 4-methyl-2-[(Z)-3-oxo-1-propenyl]phenyl acetate 
• 690630-10-5 (R)-2-tert-Butoxycarbonylamino-4-methyl-pentanoic acid 2-{(Z)-2-[(S)-1-((R)-1-{[((S)-1-tert-butoxycarbonyl-2-phenyl-ethylcarbamoyl)-methyl]-carbamoyl}-ethylcarbamoyl)-2-(4-hydroxy-phenyl)-ethylcarbamoyl]-vinyl}-4-methyl-phenyl ester 
• 690629-94-8 1-O-(N-Boc-D-leucyl)-2-[(Z)-3-(1-tert-butyl-1,1-dimethylsilyloxy)-1-propenyl]-4-methylphenol 
• 690629-96-0 1-O-(N-Boc-L-leucyl)-2-[(Z)-3-(1-tert-butyl-1,1-dimethylsilyloxy)-1-propenyl]-4-methylphenol 
• 690630-06-9 (Z)-3-[2-(1-N-Boc-D-leucyl)-4-methylphenyl]-2-propenoic acid 
• 690630-08-1 (Z)-3-[2-(1-N-Boc-L-leucyl)-4-methylphenyl]-2-propenoic acid 
• 690629-98-2 1-O-(N-Boc-D-leucyl)-2-[(Z)-3-hydroxy-1-propenyl]-4-methylphenol 
• 690630-00-3 1-O-(N-Boc-L-leucyl)-2-[(Z)-3-hydroxy-1-propenyl]-4-methylphenol 

Relevant articles and documents

The effect of substitution patterns on the release rates of opioid peptides DADLE and [Leu5]-enkephalin from coumarin prodrug moieties

A coumarin-based prodrug system has been developed in our laboratory for the preparation of esterase-sensitive prodrugs of amines, peptides, and peptidomimetics. The drug release rates from this prodrug system were found to be dependent on the structural